This conference was designed to highlight research programs within the department, expand scientific collaborations, and promote the exchange of knowledge between trainees and senior investigators.
Dr. Guo’s lab will use a combination of bioinformatics, bacterial genetics, metabolomics, and mouse models to identify the molecular mechanisms behind host-microbiome interaction.
The study, which utilized urine samples and cell-free DNA sequencing, yielded critical information on both the dynamics of infections and the patients’ particular biological responses.
This award is presented annually to members of the Weill Department of Medicine below the rank of professor who perform on outstanding levels in the areas of clinical and/or basic biomedical research.
Initiated in 2002, the award is given to fellows within the Weill Department of Medicine who have performed outstanding research. This year's finalists were presented at Medicine Grand Rounds on June 20.
This award was founded to encourage outstanding research in women’s health. The finalists presented their work at Medicine Grand Rounds.
On May 23, 2018, WDOM hosted graduation events for QUDoM Class of 2018, beginning with presentations of their quality improvement research projects at Grand Rounds.
The symposium addressed the full spectrum of health equity, from clinical research and basic sciences, to building academic community partnerships in support of scholarly projects.
The project, set to begin in January 2018, is focused on determining whether the chemopreventive effects of the COX-2 inhibitor celecoxib are exerted, in part, through altering the intestinal microbiota and gut luminal metabolites.
In this newly funded project, Drs. Choi will examine the mechanisms by which RIPK3 regulates kidney and lung fibrosis, as well as seek to uncover new biomarkers and molecular targets that can be utilized for diagnosis and treatment.
